Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
---|---|---|---|---|---|---|---|---|---|---|
Sagimet Biosciences, Inc. Class A | $267.79M | -$0.50 | ― | $0.00 | ― | ― | xxxxxxxxxxxxx | |||
Agora | $358.15M | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
Sasol | $3.10B | $1.15 | ― | $7.12B | ― | ― | xxxxxxxxxxxxx | |||
FinVolution Group | $2.34B | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
ALT5 Sigma Corporation | $156.57M | -$0.13 | ― | $5.90M | ― | ― | xxxxxxxxxxxxx | |||
Mawson Infrastructure Group | $8.31M | -$0.12 | ― | $13.70M | ― | ― | xxxxxxxxxxxxx | |||
Smart Share Global ADR | $299.18M | ― | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
Molecular Partners | $146.62M | -$0.50 | ― | $0.00 | ― | ― | xxxxxxxxxxxxx |